XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Capital in Excess of Par Value
Capital in Excess of Par Value
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Undistributed (Overdistributed) Earnings
Accumulated Undistributed (Overdistributed) Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2021     468,000,000        
Beginning balance at Dec. 31, 2021 $ 8,868 $ (2) $ 0 $ 8,553 $ (4) $ 315 $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuances of common stock (net of offering and underwriting costs) (in shares)     25,000,000        
Issuance of common stock, net of offering and underwriting costs $ 510     510      
Shares issued in connection with dividend reinvestment plan (in shares) 600,000            
Shares issued in connection with dividend reinvestment plan $ 12     12      
Net investment income 198         198  
Net realized losses on investments, foreign currency and other transactions 10         10  
Net unrealized losses on investments, foreign currency and other transactions 3         3  
Dividends declared and payable (220)         (220)  
Ending balance (in shares) at Mar. 31, 2022     493,000,000        
Ending balance at Mar. 31, 2022 9,379   $ 0 9,071   308  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuances of common stock (net of offering and underwriting costs) (in shares)     3,000,000        
Issuance of common stock, net of offering and underwriting costs 68     68      
Net investment income 257         257  
Net realized losses on investments, foreign currency and other transactions (3)         (3)  
Net unrealized losses on investments, foreign currency and other transactions (143)         (143)  
Dividends declared and payable (223)         (223)  
Ending balance (in shares) at Jun. 30, 2022     496,000,000        
Ending balance at Jun. 30, 2022 9,335   $ 0 9,139   196  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuances of common stock (net of offering and underwriting costs) (in shares)     12,000,000        
Issuance of common stock, net of offering and underwriting costs 231     231      
Net investment income 288         288  
Net unrealized losses on investments, foreign currency and other transactions (184)         (184)  
Dividends declared and payable (234)         (234)  
Ending balance (in shares) at Sep. 30, 2022     508,000,000        
Ending balance at Sep. 30, 2022 9,436   $ 0 9,370   66  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuances of common stock (net of offering and underwriting costs) (in shares)     10,000,000        
Issuance of common stock, net of offering and underwriting costs 192   $ 1 191      
Shares issued in connection with dividend reinvestment plan (in shares)     1,000,000        
Shares issued in connection with dividend reinvestment plan 17     17      
Net investment income 349         349  
Net realized losses on investments, foreign currency and other transactions 26         26  
Net unrealized losses on investments, foreign currency and other transactions (201)         (201)  
Dividends declared and payable (264)         (264)  
Tax reclassification of stockholders’ equity in accordance with GAAP 0     (22)   22  
Ending balance (in shares) at Dec. 31, 2022     519,000,000        
Ending balance at Dec. 31, 2022 9,555   $ 1 9,556   (2)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuances of common stock (net of offering and underwriting costs) (in shares)     26,000,000        
Issuance of common stock, net of offering and underwriting costs $ 477     477      
Shares issued in connection with dividend reinvestment plan (in shares) 0            
Net investment income $ 318         318  
Net realized losses on investments, foreign currency and other transactions (50)         (50)  
Net unrealized losses on investments, foreign currency and other transactions 10         10  
Dividends declared and payable (261)         (261)  
Ending balance (in shares) at Mar. 31, 2023     545,000,000        
Ending balance at Mar. 31, 2023 $ 10,049   $ 1 $ 10,033   $ 15